A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(40 sites)

China

Beijing Tsinghua Chang Gung Hospital/Infectious Diseases Department, Beijing

Peking University Shougang Hospital/Respiratory and Critical Care Medicine Department, Beijing

The First Affiliated Hospital of Bengbu Medical College/Intensive care unit, Bengbu

The Central Hospital of Changsha/Department of Respiratory and Critical Care Medicine, Changsha

The Third Hospital of Changsha/Respiratory and Critical Care Medicine Department, Changsha

Xiangya Hospital Central South University/Department of Respiratory and Critical Care Medicine, Changsha

West China Hospital of Sichuan University/Infectious Disease Center, Chengdu

The First People's Hospital of Foshan/Department of Respiratory and Critical Care Medicine, Foshan

Fuyang People's Hospital/Department of Respiratory and Critical Care Medicine, Fuyang

The First Affiliated Hospital of Gannan Medical University/Pneumology Department, Gannan

Guangdong Second Central Hospital/Department of Respiratory and Critical Care Medicine, Guangzhou

Guangzhou First People's Hospital/Respiratory and Critical Care Medicine Department, Guangzhou